Fresenius Kabi and Phlow Corp. announced today a first-of-its-kind collaboration to onshore the manufacture of Epinephrine Injection, USP, an essential medicine long at risk of chronic shortage in the ...

Fresenius Kabi and Phlow Corp. have joined forces to onshore the manufacture of Epinephrine Injection, USP in the U.S.

Novo Nordisk announced this morning it filed a lawsuit against Hims for infringing on its semaglutide patent. The drugmaker cited the FDA's announcement and warnings from organizations including the ...

Stocks in news: RIL, Tata Steel, IREDA, Kalyan Jewellers, BEML, Ipca Laboratories, Biocon, Atul Auto, JK Tyre & Industries, ...

A high-profile fight in the world of compounded drugs looks like it has been resolved, with telehealth firm Hims & Hers backing off a plan to offer a knockoff W ...

Helsinn and ESTEVE expand their partnership extending the Distribution and Licence Agreement for AKYNZEO® and ALOXI® to Austria ...

Hims & Hers unlawfully mass markets unapproved versions of Novo Nordisk’s FDA-approved semaglutide medicines, deceiving patients and putting ...

The interests of farmers and the rural economy have been protected, while 'Make in India' has been strengthened: CM ...

Helsinn and ESTEVE expand their partnership extending the Distribution and Licence Agreement for AKYNZEO and ALOXI to Austria Lugano, Switzerland - February 9th, 2026 - Helsinn Healthcare SA ("Helsinn ...

Hims & Hers unlawfully mass markets unapproved versions of Novo Nordisk’s FDA-approved semaglutide medicines, deceiving patients and putting their health at riskNovo Nordisk takes decisive legal actio ...

FDA enforcement will focus on restricting GLP-1 APIs in mass-marketed, nonapproved compounded products to address unverifiable quality, safety, and efficacy under the FD&C Act. Appropriate compounding ...

SHELTON, CONNECTICUT / ACCESS Newswire / February 2, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a ...